In a recent systematic review and meta-analysis including four observational cohort studies totaling 261,689 IBD patients an incidence rate of lymphomas of 0.34 per 1000 patient-years (95% CI: 0.30–0.37) was found in patients unexposed to either anti-TNF or thiopurines [14]. Here, TNF is linked to inflammatory bowel disease.